Back to Search
ALEXANDER COLQUHOUN, MD
MD
Anesthesiology Physician
NPI: 1598875858IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
0109541044(VA)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
OTHER
Class of 1978
Research & Publications (20)
Gamma-linolenic acid alters Ku80, E2F1, and bax expression and induces micronucleus formation in C6 glioma cells in vitro.
PMID 19180667·IUBMB Life·2009
8-other
Mechanisms of action of eicosapentaenoic acid in bladder cancer cells in vitro: alterations in mitochondrial metabolism, reactive oxygen species generation and apoptosis induction.
PMID 19237174·J Urol·2009
8-other
Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein expression.
PMID 19292920·Lipids Health Dis·2009
7-preclinical
Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.
PMID 18418552·J Neurooncol·2008
8-other
An unusual presentation of oropharyngeal mucosal plasmacytosis related to toothpaste.
PMID 17892605·J Laryngol Otol·2008
5-case
Combination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo.
PMID 17609586·J Radiat Res·2007
7-preclinical
Carbonic anhydrase IX expression and outcome after radiotherapy for muscle-invasive bladder cancer.
PMID 17706406·Clin Oncol (R Coll Radiol)·2007
8-other
Beta-hydoxy-beta-methylbutyrate supplementation affects Walker 256 tumor-bearing rats in a time-dependent manner.
PMID 17011676·Clin Nutr·2007
7-preclinical
Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
PMID 16837618·J Endocrinol·2006
8-other
Epidermal growth factor receptor status predicts local response to radical radiotherapy in muscle-invasive bladder cancer.
PMID 17100158·Clin Oncol (R Coll Radiol)·2006
8-other
Calcium modulates endopeptidase 24.15 (EC 3.4.24.15) membrane association, secondary structure and substrate specificity.
PMID 15955058·FEBS J·2005
7-preclinical
Maxillofacial fractures at Waikato Hospital, New Zealand: 1989 to 2000.
PMID 15980903·N Z Med J·2005
8-other
Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA.
PMID 15051797·J Pharmacol Exp Ther·2004
4-observational
Morphology of mitochondrial permeability transition: morphometric volumetry in apoptotic cells.
PMID 15532021·Anat Rec A Discov Mol Cell Evol Biol·2004
7-preclinical
An association between oral lichen planus and a persistently dry mouth.
PMID 15243472·Oral Surg Oral Med Oral Pathol Oral Radiol Endod·2004
8-other
The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor.
PMID 15086515·J Neurochem·2004
7-preclinical
Protective role of glucose-6-phosphate dehydrogenase activity in the metabolic response of C6 rat glioma cells to polyunsaturated fatty acid exposure.
PMID 12838507·Glia·2003
4-observational
Improving and predicting radiosensitivity in muscle invasive bladder cancer.
PMID 12771703·J Urol·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1250 E MARSHALL ST
RICHMOND, VA 23298 - Phone
- (804) 628-6975
Quick Facts
- NPI
- 1598875858
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 48
- Publications
- 20
Are you this provider?
Claim Your Profile